Coming Soon

Public Funding for Reed Medical Limited

Registration Number 02593748

healix

5,000
2015-02-01 to 2015-07-31
Vouchers
The healix range of diabetic footwear has been specifically designed to minimise the risk of plantar ulceration of the Neuropathic diabetic foot. healix footwear uses a unique patented dual axis rigid rocker sole design and polyurethane insole system. Published research indicates that a rigid rocker sole design is more effective in off-loading the mechanical stresses and strains experienced under the neuropathic foot. Reducing the magnitude and duration of pressure experienced under the neuropathic foot is now considered a priority for patients at risk of plantar ulceration. Footwear supplied to patients considered at risk of plantar ulceration should demonstrate design features to reduce the likelihood of the shoe becoming a causative factor in plantar ulceration development. To establish the effectiveness of the patented healix design, in-shoe pressure data gathered from patients living with Diabetes is key to promote confidence in the provision of this product to patients.

Get notified when we’re launching.

Want fast, powerful sales prospecting for UK companies? Signup below to find out when we're live.